LONDON Professor Chris Toumazou, the co-founder, chairman and chief technology officer Toumaz Technology Ltd. has been elected as a Fellow of the Royal Society.
Toumaz Technology (Abingdon, England) is a provider of ultra-low power wireless infrastructure for body monitoring solutions.
Professor Toumazou, a world expert in the field of low power analogue circuit design, current mode circuits and systems for radio frequency and biomedical applications, has been distinguished following a peer review process for his major advances in low-power analogue signal processing.
The Royal Society, which will celebrate its 350th anniversary in 2010, counts more than 60 Nobel Laureates amongst its approximately 1400 Fellows and Foreign Members. The honour of Fellowship to the Royal Society follows Professor Toumazou’s 2007 award of a Silver Medal from the Royal Academy of Engineering.
“Being elected a Fellow of the Royal Society is such a privilege and I feel honoured that my hard work and passion for my science has been endorsed in this way,” said professor Toumazou.
Professor Toumazou FRS co-founded Toumaz Technology in 2000 to exploit developments in ultra-low power silicon chip technology at Imperial College London. The patented core technology, Advanced Mixed Signal Processing (AMx), is the basis for Toumaz’s Sensium technology platform for intelligent wireless body monitoring.
Professor Toumazou currently holds the Winston Wong Chair in Biomedical Circuits at Imperial College London and is Director and Chief Scientist of the new Institute of Biomedical Engineering at Imperial. In recognition of his research, he was made a Professor at Imperial at the age of 33 – one of the youngest ever. He holds 23 patents, many of which are now fully granted in key territories throughout the world, and has published over 320 research papers in the field of RF and low power electronics.
Professor Toumazou has invented innovative electronic devices ranging from dual-mode cellular phones to ultra-low power devices for medical diagnosis and therapy. His pioneering research has demonstrated how the natural analogue physics of silicon semiconductor technology can be used to replace and monitor biological functions, resulting in – among other achievements – the development of one of the world's first totally implantable cochlear prosthetics. Current breakthrough research includes the development of an artificial retina and pancreas in silicon using nanowatts of power.
Professor Toumazou led a major campaign to raise £22 million to fund the creation of the Institute of Biomedical Engineering at Imperial College, which opened its purpose-built facilities in 2006. As founding Director and head of research in Bionics, Professor Toumazou’s aim is to create an international centre of excellence in biomedical engineering research – generating high quality intellectual property, and accelerating the commercial realisation of technologies to improve the lives of people around the world.
Throughout its history, the Royal Society has promoted excellence in science through its Fellowship and Foreign Membership, which has included Isaac Newton, Charles Darwin, Ernest Rutherford, Albert Einstein, Dorothy Hodgkin, Francis Crick, James Watson and Stephen Hawking.